204 related articles for article (PubMed ID: 10402157)
21. Regulation of delta opioid receptors by delta9-tetrahydrocannabinol in NG108-15 hybrid cells.
Di Toro R; Campana G; Sciarretta V; Murari G; Spampinato S
Life Sci; 1998; 63(14):PL197-204. PubMed ID: 9771917
[TBL] [Abstract][Full Text] [Related]
22. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
[TBL] [Abstract][Full Text] [Related]
23. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
24. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
26. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
[TBL] [Abstract][Full Text] [Related]
27. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
28. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.
Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC
Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal delta9-tetrahydrocannabinol exposure.
Suárez I; Bodega G; Fernández-Ruiz J; Ramos JA; Rubio M; Fernández B
Cerebellum; 2004; 3(2):66-74. PubMed ID: 15233572
[TBL] [Abstract][Full Text] [Related]
30. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
[TBL] [Abstract][Full Text] [Related]
31. Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.
Bonnin A; de Miguel R; Castro JG; Ramos JA; Fernandez-Ruiz JJ
J Mol Neurosci; 1996; 7(4):291-308. PubMed ID: 8968950
[TBL] [Abstract][Full Text] [Related]
32. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain.
Gómez M; Hernández M; Fernández-Ruiz J
Brain Res; 2007 May; 1145():48-55. PubMed ID: 17320842
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in proenkephalin gene expression response to delta9-tetrahydrocannabinol in the hypothalamus of the rat.
Corchero J; Fuentes JA; Manzanares J
J Psychopharmacol; 2002 Dec; 16(4):283-9. PubMed ID: 12503826
[TBL] [Abstract][Full Text] [Related]
34. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
35. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction.
Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T
Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322
[TBL] [Abstract][Full Text] [Related]
36. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.
González S; Cascio MG; Fernández-Ruiz J; Fezza F; Di Marzo V; Ramos JA
Brain Res; 2002 Nov; 954(1):73-81. PubMed ID: 12393235
[TBL] [Abstract][Full Text] [Related]
37. CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
Cook SA; Lowe JA; Martin BR
J Pharmacol Exp Ther; 1998 Jun; 285(3):1150-6. PubMed ID: 9618417
[TBL] [Abstract][Full Text] [Related]
38. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
Dalterio S; Steger R; Mayfield D; Bartke A
Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.
Glass M; Dragunow M; Faull RL
Neuroscience; 1997 Mar; 77(2):299-318. PubMed ID: 9472392
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation.
Koh WS; Crawford RB; Kaminski NE
Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
